Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

Introduction The majority of stage III patients with non-small cell lung cancer (NSCLC) are unsuitable for concurrent chemoradiotherapy, the non-surgical gold standard of care. As the alternative treatment options of sequential chemoradiotherapy and radiotherapy alone are associated with high local...

Full description

Bibliographic Details
Main Authors: Corinne Faivre-Finn, Kevin Franks, Fiona McDonald, Susan Harden, Gerard G Hanna, Kate Haslett, Matthew Hatton, Stephen Harrow, Linda Ashcroft, Sally Falk, Nicki Groom, Catherine Harris, Paula McCloskey, Philip Whitehurst, Neil Bayman
Format: Article
Language:English
Published: BMJ Publishing Group 2016-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/6/4/e010457.full

Internet

https://bmjopen.bmj.com/content/6/4/e010457.full

Similar Items